Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study
- PMID: 19185299
- PMCID: PMC2717185
- DOI: 10.1016/j.atherosclerosis.2008.12.013
Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study
Abstract
Objective: Dietary intake of polyunsaturated n-3 fatty acids has been associated with a reduced incidence of adverse cardiovascular events. The protective mechanisms involved are not fully understood, but may include anti-inflammatory factors. We sought to investigate the relationship between n-3 fatty acid levels in erythrocyte membranes and markers of systemic inflammation in 992 individuals with stable coronary artery disease.
Methods: Cross-sectional associations of C-reactive protein (CRP) and Interleukin-6 (Il-6) with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EHA) were evaluated in multivariable linear regression models adjusted for demographics, cardiovascular risk factors, medication use, exercise capacity, body-mass index, and waist-to-hip ratio.
Results: After multivariable adjustment, n-3 fatty acid levels (DHA+EPA) were inversely associated with CRP and IL-6. The inverse association of n-3 fatty acids with CRP and IL-6 was not modified by demographics, body-mass index, smoking, LDL-cholesterol, or statin use (p values for interaction>0.1).
Conclusions: In patients with stable coronary artery disease, an independent and inverse association exists between n-3 fatty acid levels and inflammatory biomarkers. These findings suggest that inhibition of systemic inflammation may be a mechanism by which n-3 fatty acids prevent recurrent cardiovascular events.
Figures
Similar articles
-
Relation of whole blood n-3 fatty acid levels to exercise parameters in patients with stable coronary artery disease (from the heart and soul study).Am J Cardiol. 2011 Apr 15;107(8):1149-54. doi: 10.1016/j.amjcard.2010.11.040. Am J Cardiol. 2011. PMID: 21306696
-
Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats.Eur J Pharmacol. 2011 Feb 10;652(1-3):152-6. doi: 10.1016/j.ejphar.2010.11.010. Epub 2010 Nov 29. Eur J Pharmacol. 2011. PMID: 21118685 Free PMC article.
-
Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue.Int J Cancer. 2015 Dec 15;137(12):2934-46. doi: 10.1002/ijc.29675. Epub 2015 Jul 28. Int J Cancer. 2015. PMID: 26137879
-
Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.Evid Rep Technol Assess (Full Rep). 2016 Aug;(223):1-1252. doi: 10.23970/AHRQEPCERTA223. Evid Rep Technol Assess (Full Rep). 2016. PMID: 30307737
-
Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.Herz. 2004 Nov;29(7):673-85. doi: 10.1007/s00059-004-2602-4. Herz. 2004. PMID: 15580322 Review.
Cited by
-
DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.Expert Opin Drug Discov. 2012 Aug;7(8):711-21. doi: 10.1517/17460441.2012.694862. Epub 2012 Jun 24. Expert Opin Drug Discov. 2012. PMID: 22724444 Free PMC article. Review.
-
Omega-3 index and cardiovascular health.Nutrients. 2014 Feb 21;6(2):799-814. doi: 10.3390/nu6020799. Nutrients. 2014. PMID: 24566438 Free PMC article. Review.
-
A new insight to bone turnover: role of ω-3 polyunsaturated fatty acids.ScientificWorldJournal. 2013 Nov 4;2013:589641. doi: 10.1155/2013/589641. ScientificWorldJournal. 2013. PMID: 24302863 Free PMC article. Review.
-
Association of red blood cell n-3 polyunsaturated fatty acids with plasma inflammatory biomarkers among the Quebec Cree population.Eur J Clin Nutr. 2014 Sep;68(9):1042-7. doi: 10.1038/ejcn.2014.125. Epub 2014 Jul 16. Eur J Clin Nutr. 2014. PMID: 25028086
-
The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly.Curr Neuropharmacol. 2018 Mar 5;16(3):308-326. doi: 10.2174/1570159X15666170912113852. Curr Neuropharmacol. 2018. PMID: 28901279 Free PMC article. Review.
References
-
- Breslow JL. N-3 Fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83(S):1477S–1482S. - PubMed
-
- Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 Fatty Acids for Cardioprotection. Mayo Clin Proc. 2008;83(3):324–332. - PubMed
-
- Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193(1):1–10. - PubMed
-
- Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–1118. - PubMed
-
- Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197(1):12–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous